These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 20123920)

  • 21. Catatonia, autism, and ECT.
    Zaw FK; Bates GD; Murali V; Bentham P
    Dev Med Child Neurol; 1999 Dec; 41(12):843-5. PubMed ID: 10619284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electroconvulsive Therapy-Resistant Catatonia: Case Report and Literature Review.
    Hasoglu T; Francis A; Mormando C
    J Acad Consult Liaison Psychiatry; 2022; 63(6):607-618. PubMed ID: 35842127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practical and Legal Challenges to Electroconvulsive Therapy in Malignant Catatonia.
    Shenai N; White CD; Azzam PN; Gopalan P; Solai LK
    Harv Rev Psychiatry; 2016; 24(3):238-41. PubMed ID: 27148914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome.
    Addonizio G; Susman VL
    J Clin Psychiatry; 1987 Mar; 48(3):102-5. PubMed ID: 2880837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rocuronium-sugammadex decreases the severity of post-electroconvulsive therapy agitation.
    Postaci A; Tiryaki C; Sacan O; Ornek D; Kalyoncu M; Dikmen B
    J ECT; 2013 Mar; 29(1):e2-3. PubMed ID: 23422529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catatonia after cerebral hypoxia: do the usual treatments apply?
    Quinn DK; Abbott CC
    Psychosomatics; 2014; 55(6):525-35. PubMed ID: 25262046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electroconvulsive therapy (ECT) in a six-year-old girl suffering from major depressive disorder with catatonic features.
    Esmaili T; Malek A
    Eur Child Adolesc Psychiatry; 2007 Feb; 16(1):58-60. PubMed ID: 16791543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal competency in catatonia.
    Bostwick JM; Chozinski JP
    J Am Acad Psychiatry Law; 2002; 30(3):371-6. PubMed ID: 12380416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ECT for lorazepam-refractory catatonia.
    Yeung PP; Milstein RM; Daniels DC; Bowers MB
    Convuls Ther; 1996 Mar; 12(1):31-5. PubMed ID: 8777651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment-refractory catatonia, ECT, and parenteral lorazepam.
    Koek RJ; Mervis JR
    Am J Psychiatry; 1999 Jan; 156(1):160-1; author reply 161. PubMed ID: 9892323
    [No Abstract]   [Full Text] [Related]  

  • 31. Encephalitis and catatonia treated with ECT.
    Ali S; Welch CA; Park LT; Pliakas AM; Wilson A; Nicolson S; Huffman J; Fricchione GL
    Cogn Behav Neurol; 2008 Mar; 21(1):46-51. PubMed ID: 18327024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Life-saving electroconvulsive therapy in a patient with near-lethal catatonia.
    Girardi P; Rapinesi C; Cuomo I; Kotzalidis GD; Del Casale A; Serata D; Campi S; Caloro M; De Chiara L; Tamorri SM; Scatena P; Caccia F; Bersani FS; Carbonetti P; Vento A; Dimitri-Valente G; Tatarelli R; Fensore C; Ferracuti S; Angeletti G
    Riv Psichiatr; 2012; 47(6):535-7. PubMed ID: 23160114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance electroconvulsive therapy for depression with catatonia in a young woman with Down syndrome.
    Torr J; D'Abrera JC
    J ECT; 2014 Dec; 30(4):332-6. PubMed ID: 24755717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electroconvulsive therapy without consent from patients: one-year follow-up study.
    Chiu NM; Lee Y; Lee WK
    Asia Pac Psychiatry; 2014 Mar; 6(1):83-90. PubMed ID: 23857906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment-refractory catatonia, ECT, and parenteral lorazepam.
    Armstrong SC
    Am J Psychiatry; 1999 Jan; 156(1):160; author reply 161. PubMed ID: 9892322
    [No Abstract]   [Full Text] [Related]  

  • 36. ECT and the youth: catatonia in context.
    Zaw FK
    Int Rev Neurobiol; 2006; 72():207-31. PubMed ID: 16697300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuromuscular blocking agents for electroconvulsive therapy: a systematic review.
    Mirzakhani H; Welch CA; Eikermann M; Nozari A
    Acta Anaesthesiol Scand; 2012 Jan; 56(1):3-16. PubMed ID: 22092267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electroconvulsive therapy for catatonia resulting in cardiac arrest.
    Bailey C; Venn R; Panayiotou S; Chojnowska E; Gorst-Unsworth C; Cavanagh R; Caldwell G; Wong S
    Eur J Anaesthesiol; 2006 Sep; 23(9):812-4. PubMed ID: 16884558
    [No Abstract]   [Full Text] [Related]  

  • 39. Does rocuronium-sugammadex reduce myalgia and headache after electroconvulsive therapy in patients with major depression?
    Saricicek V; Sahin L; Bulbul F; Ucar S; Sahin M
    J ECT; 2014 Mar; 30(1):30-4. PubMed ID: 23812022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroleptic malignant syndrome and mivacurium: a safe alternative to succinylcholine?
    Kelly D; Brull SJ
    Can J Anaesth; 1994 Sep; 41(9):845-9. PubMed ID: 7955001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.